Related Experiment Video
Updated: Feb 22, 2026

Assessing Functional Performance in the Mdx Mouse Model
Published on: March 27, 2014
Cardiac Performance Evaluation in Patients with Muscular Dystrophy
Naomi Khanna1, Joseph Mahgerefteh2, Noah Elkins3
1Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
Ventriculoarterial coupling (VAC) is impaired in muscular dystrophy (MD) patients and worsens over time. Reduced cardiac function in MD is linked to ambulation status, offering insights into disease progression.
Area of Science:
- Cardiology
- Neuromuscular Disorders
- Biomedical Engineering
Background:
- Ventriculoarterial coupling (VAC) assesses the relationship between ventricular performance and arterial stiffness.
- Muscular dystrophy (MD) is associated with various systemic complications, including cardiac involvement.
Purpose of the Study:
- To investigate if VAC is abnormal in muscular dystrophy (MD) patients.
- To determine if VAC worsens with disease progression in MD.
- To identify factors associated with abnormal VAC in MD.
Main Methods:
- Echocardiograms were used to calculate arterial elastance (Ea) and LV end-systolic elastance (Ees) in MD patients and controls.
- VAC was compared between initial and follow-up studies in MD patients.
- Regression analyses identified factors associated with VAC.
Main Results:
- MD patients exhibited significantly lower ejection fraction (EF) and Ees, and a higher VAC ratio compared to controls.
- Cardiac dysfunction worsened over the follow-up period in MD patients.
- Ambulation status was independently associated with EF and Ees at last follow-up.
Conclusions:
- Cardiac performance, measured by VAC, is impaired in MD patients and deteriorates longitudinally.
- Ambulation status is a key factor associated with cardiac dysfunction in MD.
- Findings provide mechanistic insights into cardiac dysfunction progression in MD.
More Related Videos
14:10Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies
Published on: January 31, 2013
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Pathophysiology of Cardiac Performance
Cardiomyopathy VI: Nursing Management
Dysrhythmias V: Evaluating Dysrhythmias